期刊文献+

三烯高诺酮和米非司酮对离体大鼠及人体子宫内膜生长的抑制作用 被引量:6

Effect of gestrinone and mifepristone on the growth of cultured rat and human endometrium
暂未订购
导出
摘要 大鼠子宫内膜离体培养4天后分组给药:对照组;丹那唑10-6,3×10-6,10-5mol/L;三烯高诺酮3×10-8,1O-7,3×1O-7mol/L;米非司酮10-6,10-5,10-4mol/L。于给药5天后取培养子宫内膜切片,镜下观察其形态变化,全自动图象分析仪细胞计数。结果表明,丹那唑抑制大鼠子宫内膜的生长,而三烯高诺酮和米非司酮未见明显抑制效应。人体子宫内膜离体培养4天后分组给药,1O-9mol/L雌二醇、10-7mol/L孕酮均能促进子宫内膜的生长。在给雌二醇或孕酮的同时加3×10-6mol/L丹那唑或10-7mol/L三烯高诺酮或1O-5mol/L米非司酮。结果表明,丹那唑、三烯高诺酮和米非司酮均能抑制子宫内膜的生长,而在雌二醇或孕酮缺乏的条件下,三烯高诺酮和米非司酮对子宫内膜的生长没有明显抑制作用。此结果表明三烯高诺酮和米非司酮对子宫内膜生长的抑制作用有赖于雌二醇或孕酮的存在。 The aim of the present study is to investigate the effect of gestrinone and mifepristone on the growth of rat and human endometrium in vitro. In vitro of rat endometrium was treated with l0-6, 3 × 10-6,1O-5mol / L danazol,3 × 10-8,1O-7,3 × 10-7mol / L gestrinone and l0-6 ,1O-5, 10-4mol / L mifepristone for 96 hours in separate groups. The morphologic features of endometrium were evaluated quantitatively by automatic image analysis system. The results showed that danazol inhibited the growth of endometrium, but no significant inhibition was detected in gestrinone and mifepristone groups. Endometrium of women in culture was treated with 10-9mol / L estradiol, 1O-7mol / L progesterone,3×x 10-6mol/ L danazol,1O-7mol/L gestrinone or l0-5mol / L mifepristone for 96 hours in separate groups.The results showed that estradiol or progesterone stimulated proliferation of endometrium, and these effects can be inhibited by gestrinone or mifepristone.
出处 《生殖医学杂志》 CAS 1994年第4期204-207,共4页 Journal of Reproductive Medicine
关键词 三烯高诺酮 米非司酮 子宫内膜 子宫内膜异位 Gestrinone Mifepristone Endometrium
  • 相关文献

同被引文献49

  • 1张俊慧,陆湘云,颜本元.应用GnRH—A治疗子宫肌瘤34例分析[J].实用妇产科杂志,1995,11(1):35-36. 被引量:14
  • 2李克敏,杨幼林,郑淑蓉,张炳兰.小剂量米非司酮治疗子宫肌瘤[J].北京医科大学学报,1996,28(3):216-217. 被引量:14
  • 3杨幼林,郑淑蓉,李克敏,张炳兰.两种不同剂量米非司酮治疗子宫肌瘤的疗效观察[J].中华妇产科杂志,1996,31(10):624-626. 被引量:217
  • 4陈湘云,罗启东.微波治疗脱入阴道的子宫粘膜下肌瘤[J].中华妇产科杂志,1997,32(1):30-30. 被引量:21
  • 5[2]Englund K,Blanck A,Gustarsson I,et al. Sex steroid receptors in human myometrium and fibroids :Changes during the menstrual cycle and gonadotropin_ releasing hormone treatment[J]. Clin Endocrinol Metab, 1998,83 : 4 092~ 4 096
  • 6[4]Filicori M. A Conservative approach to the management of uterine leiomyoma:Pituitary desenstitization by a Luteinizing hormone_releasing analogue[J]. An J Obster Gynecol, 1983,147:726
  • 7[6]Deligdisch L,Hirschmann S,Altchek A. Pathologic Changes in Gonadotropin Releasing Hormone Agonist Analogue Treated Uterine Leiomyomata [J]. Fertil Steril, 1997, 67(5) :837~841
  • 8[7]Palomba S,Affinito P,Tommaselli GA,et al. A clinical trial of the effects of tibolone administered with gonadotropinreleasing hormone analogues for the treatment of uterine leiomyomata [J]. Fertil Steril, 1998,70 (1): 111 ~ 118
  • 9[9]Murphy AA, Kettel LM, Morales AJ, et al. Regression of uterine Leiomyoma in response to the antiprogesterone RU486[J]. J Clin Endocrinol Metab,1993,76(2) :513~517
  • 10[19]Harima Y, Harima K, Hasegawa T, et al. Histopathological changes in rabbit uterus carcinoma after transcatheterarterial embolization using cisplatin[J]. Cancer Chemother Pharmacol, 1996,38(4): 317~322

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部